Drug pricing didn’t come up in White House biomedical meeting, NIH director says

drug-pricing-didnt-come-up-in-white-house-biomedical-meeting-nih-director-says

It was an elephant in the room: Drug pricing has been a key focus of President Donald Trump’s narrative on the drug industry since even before he took office.
Read more here.


Leave a Reply

Your email address will not be published. Required fields are marked *


Home / Featured (sidebar) / Drug pricing didn’t come up in White House biomedical meeting, NIH director says